---
title: "Touyun Biotech Group posts FY revenue HKD 67 million"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/280818191.md"
description: "Touyun Biotech Group posts FY revenue HKD 67 million"
datetime: "2026-03-27T15:27:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280818191.md)
  - [en](https://longbridge.com/en/news/280818191.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280818191.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/280818191.md) | [繁體中文](https://longbridge.com/zh-HK/news/280818191.md)


# Touyun Biotech Group posts FY revenue HKD 67 million



### 相关股票

- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-CN/quote/159849.CN.md)
- [TOUYUN BIOTECH (01332.HK)](https://longbridge.com/zh-CN/quote/01332.HK.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-CN/quote/516500.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-CN/quote/516930.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-CN/quote/159837.CN.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)

## 相关资讯与研究

- [UCB presents new Bimzelx data at AAD](https://longbridge.com/zh-CN/news/280813909.md)
- [Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines](https://longbridge.com/zh-CN/news/280923090.md)
- [TransThera Sciences Widens Annual Loss Amid Continued R&D Spend](https://longbridge.com/zh-CN/news/281187419.md)
- [Sunho Biologics Flags Audit Delays as Auditor Seeks More Documentation](https://longbridge.com/zh-CN/news/280992698.md)
- [Novo Nordisk Wins FDA Nod for First Once‑Weekly Basal Insulin Awiqli in U.S.](https://longbridge.com/zh-CN/news/280789111.md)